142 related articles for article (PubMed ID: 10721800)
1. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes.
Omri A; Makabi-Panzu B; Agnew BJ; Sprott GD; Patel GB
J Drug Target; 2000; 7(5):383-92. PubMed ID: 10721800
[TBL] [Abstract][Full Text] [Related]
2. Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes.
Omri A; Agnew BJ; Patel GB
Int J Toxicol; 2003; 22(1):9-23. PubMed ID: 12573945
[TBL] [Abstract][Full Text] [Related]
3. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein.
Makabi-Panzu B; Sprott GD; Patel GB
Vaccine; 1998 Oct; 16(16):1504-10. PubMed ID: 9711796
[TBL] [Abstract][Full Text] [Related]
4. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
Patel GB; Sprott GD
Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
[TBL] [Abstract][Full Text] [Related]
5. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
6. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
Sprott GD; Sad S; Fleming LP; Dicaire CJ; Patel GB; Krishnan L
Archaea; 2003 Oct; 1(3):151-64. PubMed ID: 15803661
[TBL] [Abstract][Full Text] [Related]
7. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
[TBL] [Abstract][Full Text] [Related]
8. Archaeosome immunostimulatory vaccine delivery system.
Patel GB; Chen W
Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
[TBL] [Abstract][Full Text] [Related]
9. In vitro assessment of archaeosome stability for developing oral delivery systems.
Patel GB; Agnew BJ; Deschatelets L; Fleming LP; Sprott GD
Int J Pharm; 2000 Jan; 194(1):39-49. PubMed ID: 10601683
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the tissue distribution of coenzyme Q10 intravenously administered in an emulsion to rats: emulsifying agents and lipoprotein lipase activity.
Kimura A; Yamaguchi H; Watanabe K; Hayashi M; Awazu S
J Pharm Pharmacol; 1986 Sep; 38(9):659-62. PubMed ID: 2877065
[TBL] [Abstract][Full Text] [Related]
11. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
McCluskie MJ; Deschatelets L; Krishnan L
Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
[TBL] [Abstract][Full Text] [Related]
14. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
Bhagavan HN; Chopra RK
Mitochondrion; 2007 Jun; 7 Suppl():S78-88. PubMed ID: 17482886
[TBL] [Abstract][Full Text] [Related]
15. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes.
Sprott GD; Brisson J; Dicaire CJ; Pelletier AK; Deschatelets LA; Krishnan L; Patel GB
Biochim Biophys Acta; 1999 Sep; 1440(2-3):275-88. PubMed ID: 10521711
[TBL] [Abstract][Full Text] [Related]
16. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
17. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2001 Feb; 166(3):1885-93. PubMed ID: 11160236
[TBL] [Abstract][Full Text] [Related]
18. Primary coenzyme Q10 deficiency and the brain.
Naini A; Lewis VJ; Hirano M; DiMauro S
Biofactors; 2003; 18(1-4):145-52. PubMed ID: 14695930
[TBL] [Abstract][Full Text] [Related]
19. 11C-coenzyme Q10: a new myocardial imaging tracer for positron emission tomography.
Ishiwata K; Miura Y; Takahashi T; Kawashima K; Yanai K; Monma M; Ido T
Eur J Nucl Med; 1985; 11(5):162-5. PubMed ID: 3877633
[TBL] [Abstract][Full Text] [Related]
20. Archaeosomes as novel antigen delivery systems.
Sprott GD; Tolson DL; Patel GB
FEMS Microbiol Lett; 1997 Sep; 154(1):17-22. PubMed ID: 9297816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
